All
A Great Display of Healing in Cancer Care
A colleague wrote about a dedicated oncology nurse who excels in patient care, demonstrates exceptional clinical skills and consistently goes above and beyond to improve patient outcomes.
Removing Fewer Lymph Nodes May Reduce Lymphedema Risk in Breast Cancer
An expert explained how sentinel lymph node biopsy has helped surgeons remove fewer lymph nodes, which can reduce lymphedema risk in patients with breast cancer.
GERD Might Cause Colonoscopy Avoidance. But Don’t Let It
I initially put off a colonoscopy due to gastroesophageal reflux disease, but after a positive home screening test, I underwent the procedure and was diagnosed with stage 3 rectal cancer.
Application Submitted to FDA for Avutometinib Plus Defactinib in Rare Ovarian Cancer
The FDA received the New Drug Application for avutometinib plus defactinib as a potential treatment option for previously treated low-grade serous ovarian cancer.
Oncology Drugs Approved by the FDA in October 2024
During October, the FDA approved drugs to treat diseases including breast cancer, lung cancer, leukemia and gastric cancer.
More Women Are Finding Their Voices After a Breast Cancer Diagnosis
After my breast cancer diagnosis, I decided to take a more active role in my treatment plan, opting for radiation therapy over chemotherapy due to concerns about side effects.
Yankees Gift World Series Tickets to Pediatric Patient, “The Warriors” Star Dies and More
From World Series tickets given to a pediatric patient with cancer to the death of David Harris, known as Cochise in “The Warriors,” at the age of 75, here is this week’s cancer news.
Early Data Demonstrate Ablation May Alleviate Pain From Pancreatic Cancer
In the first 15 patients, radiofrequency ablation was shown to reduce pain scores in most patients with pancreatic cancer.
First Patients Dosed in Three Trials Assessing Dato-DXd-Based Regimens in Lung Cancer
Three phase 3 trials will assess datopotamab deruxtecan-based treatments in patients with nonsquamous non-small cell lung cancer.
Opdivo and Yervoy May Improve Survival for Resected Stage 3/4 Melanoma
Patients with resected stage 3 or 4 melanoma treated with immune-oncology agents demonstrated significantly higher cure rates compared to those treated with placebo.
A Month Without Pink, Almost
Preoccupied with other worries during October, a month full of cancer anniversaries, I reflect on how Pinktober caught up with me.
Inrebic May Reduce Spleen Volume in Myelofibrosis
Second-line treatment with Inrebic has been shown to be beneficial for patients with myelofibrosis previously treated with Jakafi.
FDA Warns Against Use of BioZorb Markers
The agency is alerting patients and providers to not use the implantable devices, made for soft tissue such as breast tissue.
Connecting With Others Can Benefit the Greater Breast Cancer Community
In this on-demand webinar series, CURE partnered with Susan G. Komen Foundation and Roswell Park Comprehensive Cancer Center to learn more about how patients with breast cancer can connect with each other.
Self-Advocacy Remains Critical During Breast Cancer
CURE partnered with Susan G. Komen Foundation and Roswell Park Comprehensive Cancer Center for a webinar to discuss the importance of self-advocacy.
Sharing Experiences to Empower Other Patients With Breast Cancer
In this on-demand webinar series, CURE partnered with Susan G. Komen Foundation and Roswell Park Comprehensive Cancer Center to discuss supporting others with breast cancer.
CAR-T Cell Therapy Receives FDA Designation in Kidney Cancer Subset
Regenerative Medicine Advanced Therapy designation was granted to an investigational CAR-T cell therapy for some patients with renal cell carcinoma.
The Never-Ending Cycle of Cancer: Treatment Versus Long-Term Health
My daughter faced the difficult decision of balancing the potential benefits and risks of cancer treatment, including the long-term heart complications associated with Herceptin.
Current Treatment May Be Superior to Recentin In Ovarian Cancer
Treatment containing Recentin demonstrated clinical benefits, but it proves worse than the current standard care treatment.
Balancing Decisions Around Breast Cancer Treatment and Fertility, Breastfeeding
An expert discussed how patients with breast cancer, particularly those with a BRCA mutation, should consider future fertility and breastfeeding when making treatment decisions.
First Patients Dosed in Phase 2 Trial of Ropidoxuridine for Glioblastoma
A phase 2 clinical trial of a new brain cancer treatment is underway.
FDA Approves Scemblix for Some With Newly Diagnosed Chronic Myeloid Leukemia
Treatment with Scemblix was shown to improve response rates in patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia in the chronic phase.
Prostate Cancer Questions Answered, From PSA Levels to Treatment Decisions
An expert answers prostate cancer questions from a recent CURE Educated Patient Summit.
FDA Expands Approval for Jylamvo to Children With Acute Lymphoblastic Leukemia
Jylamvo is an oral liquid formulation of methotrexate originally approved in 2022 for adults with acute lymphoblastic leukemia, among other diseases.
Patients With Cancer Can Benefit from Palliative Care Earlier
An expert told CURE that patients with cancer should discuss palliative care options with their team “as early as possible.”
Phase 3 Trial Begins in mRNA-Based Therapy Plus Keytruda in Non-Small Cell Lung Cancer
This trial will assess an individualized neoantigen therapy plus Keytruda in some patients with non-small cell lung cancer.
Stivarga Improves Survival in Refractory Advanced Gastric Cancer
Stivarga improved survival and delayed disease progression in patients with refractory advanced gastric and esophagogastric junction cancer.
My Family’s Strong Support During My Experience With Colon Cancer
Carla Deschamps shares her experience with colon cancer and how her brother, sisters and parents helped her through the journey.
Radiation May Cause Secondary Cancer in Some Breast Cancers
Receiving radiation therapy for breast cancers harboring TP53 germline variants may cause secondary cancers, but risk estimates are unconfirmed.
Monitoring Treatment With Different Types of Biopsies in Lung Cancer
An expert discussed how liquid and tissue biopsies can help monitor treatment and detect potential resistance in patients with non-small cell lung cancer.